InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the full record of transactions filed by Mai Xiaoying, 董事. Director active across 1 company, notably Twist Bioscience Corp. In total, 4 filings have been published. History available since 7 February 2022. The latest transaction was filed on 6 February 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Mai Xiaoying
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
5,815 股0Common StockSEC:0001214659-24-002248:0
8,212 股0Common StockSEC:0001214659-23-001877:0
3,491 股0Common StockSEC:0001214659-22-002203:0
13,539 股0Common StockSEC:0001214659-22-002109:0
4 条申报中的 4 条
About Mai Xiaoying
Jill Carroll is a Director at Arcellx, Inc. As a board member, she participates in strategic decision-making and oversight of the company's performance. Jill brings valuable expertise through her experience in the industry.
